Northern Trust Corp Liquidia Corp Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Liquidia Corp stock. As of the latest transaction made, Northern Trust Corp holds 438,600 shares of LQDA stock, worth $4.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

438,600

Previous 446,084 1.68%

Holding current value

$4.83 Million

Previous $6.58 Million 20.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.96 - $15.71 $89,508 - $117,573	-7,484 Reduced 1.68%	438,600 $5.26 Million
Q1 2024 May 14, 2024	BUY	$11.35 - $16.73 $333,542 - $491,644	29,387 Added 7.05%	446,084 $6.58 Million
Q4 2023 Feb 13, 2024	BUY	$5.77 - $12.19 $80,208 - $169,453	13,901 Added 3.45%	416,697 $5.01 Million
Q3 2023 Nov 13, 2023	BUY	$6.27 - $8.15 $45,206 - $58,761	7,210 Added 1.82%	402,796 $2.55 Million
Q2 2023 Aug 11, 2023	SELL	$6.63 - $9.9 $4,309 - $6,435	-650 Reduced 0.16%	395,586 $3.11 Million
Q1 2023 May 15, 2023	BUY	$5.72 - $7.91 $44,209 - $61,136	7,729 Added 1.99%	396,236 $2.74 Million
Q4 2022 Feb 13, 2023	SELL	$4.68 - $6.54 $40,004 - $55,903	-8,548 Reduced 2.15%	388,507 $2.47 Million
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $43,439 - $97,709	-11,646 Reduced 2.85%	397,055 $2.16 Million
Q2 2022 Aug 12, 2022	BUY	$3.37 - $7.55 $1.13 Million - $2.54 Million	336,794 Added 468.37%	408,701 $1.78 Million
Q1 2022 May 13, 2022	BUY	$5.14 - $7.38 $606 - $870	118 Added 0.16%	71,907 $516,000
Q2 2021 Aug 13, 2021	SELL	$2.51 - $3.11 $532,908 - $660,296	-212,314 Reduced 74.73%	71,789 $205,000
Q1 2021 May 12, 2021	SELL	$2.42 - $3.6 $54,670 - $81,327	-22,591 Reduced 7.37%	284,103 $765,000
Q4 2020 Feb 11, 2021	BUY	$2.6 - $5.79 $17,968 - $40,014	6,911 Added 2.31%	306,694 $905,000
Q3 2020 Nov 16, 2020	BUY	$4.34 - $8.28 $307,215 - $586,116	70,787 Added 30.91%	299,783 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $355,484 - $836,778	73,145 Added 46.93%	228,996 $1.93 Million
Q1 2020 May 14, 2020	BUY	$3.31 - $7.15 $73,746 - $159,302	22,280 Added 16.68%	155,851 $734,000
Q4 2019 Feb 14, 2020	SELL	$3.07 - $5.11 $34,230 - $56,976	-11,150 Reduced 7.7%	133,571 $571,000
Q3 2019 Nov 13, 2019	BUY	$3.29 - $8.24 $191,323 - $479,180	58,153 Added 67.18%	144,721 $515,000
Q2 2019 Aug 13, 2019	BUY	$7.92 - $11.39 $102,571 - $147,511	12,951 Added 17.59%	86,568 $693,000
Q1 2019 May 13, 2019	BUY	$10.82 - $21.79 $187,012 - $376,618	17,284 Added 30.68%	73,617 $838,000
Q4 2018 Feb 12, 2019	BUY	$16.38 - $37.18 $79,672 - $180,843	4,864 Added 9.45%	56,333 $1.22 Million
Q3 2018 Nov 14, 2018	BUY	$10.96 - $28.9 $564,100 - $1.49 Million	51,469 New	51,469 $1.41 Million

Others Institutions Holding LQDA

# of Institutions

163

Shares Held

36M

Call Options Held

1.79M

Put Options Held

380K

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Liquidia Corp Transaction History